Literature DB >> 32434823

Rheumatic diseases in intensive care unit patients with COVID-19.

Sergey Moiseev1, Sergey Avdeev2, Michail Brovko3, Andrey Yavorovskiy4, Pavel I Novikov3, Karina Umbetova5, Larisa Akulkina3, Natal'ya Tsareva2, Victor Fomin6.   

Abstract

Entities:  

Keywords:  antirheumatic agents; autoimmune diseases; cytokines

Mesh：

Year:  2020        PMID： 32434823     DOI： 10.1136/annrheumdis-2020-217676

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

1.  Autoimmune Diseases and COVID-19 as Risk Factors for Poor Outcomes: Data on 13,940 Hospitalized Patients from the Spanish Nationwide SEMI-COVID-19 Registry.

Authors:  María Del Mar Ayala Gutiérrez; Manuel Rubio-Rivas; Carlos Romero Gómez; Abelardo Montero Sáez; Iván Pérez de Pedro; Narcís Homs; Blanca Ayuso García; Carmen Cuenca Carvajal; Francisco Arnalich Fernández; José Luis Beato Pérez; Juan Antonio Vargas Núñez; Laura Letona Giménez; Carmen Suárez Fernández; Manuel Méndez Bailón; Carlota Tuñón de Almeida; Julio González Moraleja; Mayte de Guzmán García-Monge; Cristina Helguera Amezua; María Del Pilar Fidalgo Montero; Vicente Giner Galvañ; Ricardo Gil Sánchez; Jorge Collado Sáenz; Ramon Boixeda; José Manuel Ramos Rincón; Ricardo Gómez Huelgas
Journal:  J Clin Med       Date:  2021-04-23       Impact factor: 4.241

2.  Pharmacotherapeutic considerations for systemic rheumatic diseases amid the COVID-19 pandemic: more questions than answers.

Authors:  Chia Siang Kow; Syed Shahzad Hasan
Journal:  Drugs Ther Perspect       Date:  2020-08-16

3.  COVID-19, rheumatic diseases and immune dysregulation-a perspective.

Authors:  Shahna Tariq; Charmaine Van Eeden; Jan Willem Cohen Tervaert; Mohammed S Osman
Journal:  Clin Rheumatol       Date:  2021-01-07       Impact factor: 2.980

Review 4.  COVID-19 and systemic sclerosis: Rising to the challenge of a pandemic.

Authors:  Christopher P Denton; Corrado Campochiaro; Cosimo Bruni; Oliver Distler; Annamaria Iagnocco; Marco Matucci Cerinic
Journal:  J Scleroderma Relat Disord       Date:  2020-10-18

Review 5.  Systemic sclerosis in the time of COVID-19.

Authors:  Anna-Maria Hoffmann-Vold; Oliver Distler; Cosimo Bruni; Christopher P Denton; Jeska de Vries-Bouwstra; Marco Matucci Cerinic; Madelon C Vonk; Armando Gabrielli
Journal:  Lancet Rheumatol       Date:  2022-07-21

Review 6.  Interplay of diabetes mellitus and rheumatic diseases amidst the COVID-19 pandemic: influence on the risk of infection, outcomes, and immune responses.

Authors:  Pankti Mehta; Armen Yuri Gasparyan; Olena Zimba; George D Kitas; Marlen Yessirkepov
Journal:  Clin Rheumatol       Date:  2022-09-09       Impact factor: 3.650

7.  SARS-CoV-2 infection in an advanced rheumatoid arthritis patient.

Authors:  Ahmadreza Bazmjoo; Mohammad Aref Bagherzadeh; Farida Farahmandpoor; Rahim Raoofi; Amir Abdoli
Journal:  APMIS       Date:  2020-10-07       Impact factor: 3.428

8.  COVID-19 in Italian Sjögren's syndrome patients: a monocentric study.

Authors:  F Giardina; R Izzo; A Gattamelata; S Colafrancesco; F Conti; R Priori
Journal:  Rheumatol Int       Date:  2020-10-18       Impact factor: 2.631
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.